A prospective observational multiple centre cohort study of relapsing-remitting multiple sclerosis treated with Rebif© or Betaseron in the Netherlands: a societal cost analysis

Research output: Book/ReportReportProfessional

Original languageEnglish
Place of PublicationMaastricht
PublisherMaastricht University
Publication statusPublished - 1 Jan 2015

Cite this